Document Detail


Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional study.
MedLine Citation:
PMID:  9693238     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To substantiate differences in magnetic resonance (MR) patterns in clinical subgroups of multiple sclerosis (MS), we analyzed T2-weighted MR images of a large regional population of MS patients (n = 188). The patients had already been classified according to recent consensus definitions regarding the clinical course of MS into relapsing-remitting (RR), secondary progressive (SP) or primary progressive (PP). Significant (p < 0.01; Spearman test) differences were present between RR and SP patients regarding total lesion load, size and location of lesions. RR and PP patients showed similar MR patterns. PP and SP patients differed in total lesion load, small and medium-sized lesions. The degree of atrophy was highest for SP patients. The clinical progression rate [Expanded Disability Status Scale (EDSS)/disease duration] was similar for various subgroups; the MR progression rate (total lesion score/disease duration) was significantly larger for SP than for PP patients. The lesions load disability quotient (total lesion load/EDSS) differed between RR and PP patients and also between SP and PP patients. In SP patients, the total lesion load correlated significantly (Spearman rank correlation coefficient of 0.52) with EDSS. We conclude that PP patients differ in MR abnormalities from SP patients, that PP and RR patients have similar MR abnormalities and that RR and SP patients are at a different end of the same spectrum of the disease. As the dynamics and clinical impact of MS lesions are different in the various clinical subgroups, they should be considered separately in clinical trials.
Authors:
M A van Walderveen; F Barkhof; M W Tas; C Polman; S T Frequin; O R Hommes; A J Thompson; J Valk
Related Documents :
546678 - Geographical disproportions of multiple sclerosis in czechoslovakia.
16618908 - Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
11721128 - The prevalence of multiple sclerosis, distribution of clinical forms of the disease and...
15729518 - Intrathecal sicam-1 production in multiple sclerosis--correlation with triple dose gd-d...
23197348 - Sunct, suna and pituitary tumors: clinical characteristics and treatment.
19886308 - Use of peritoneal dialysis and mesothelium in non primary renal conditions.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European neurology     Volume:  40     ISSN:  0014-3022     ISO Abbreviation:  Eur. Neurol.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-10-14     Completed Date:  1998-10-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0150760     Medline TA:  Eur Neurol     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  91-8     Citation Subset:  IM    
Affiliation:
MR Center for MS Research and Departments of Radiology, Academic Hospital 'Vrije Universiteit', Amsterdam, The Netherlands. m.vanwalderveen@azvu.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Atrophy / pathology
Cross-Sectional Studies
Disease Progression
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis / pathology*
Radiopharmaceuticals / diagnostic use
Retrospective Studies
Severity of Illness Index
Technetium / diagnostic use
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 7440-26-8/Technetium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Motor perseverations: a function of the side and the site of a cerebral lesion.
Next Document:  Lesion localization in developing poststroke hand dystonia.